Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

Richard Oakley of the Alzheimer's Society spoke to Newsweek about why now is an "exciting time" in the battle against the ...

Antidepressants can be very effective, but they also come with side effects that vary from one drug to the next, supporting ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

Joining me now is Manoj Bhargava, Founder and CEO of Cerezen. His company is also the largest shareholder of our parent ...

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

THERE'S BEEN A wave of new therapies for Alzheimer’s disease released over the last few years. But nothing would be as revolutionary as simply taking a pill to slow down cognitive decline. Better yet, ...

Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...

Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first medication ...